Login to Your Account



Earnings Roundup


Thursday, February 14, 2013
• Acorda Therapeutics Inc., of Ardsley, N.Y., beat analyst estimates with its net revenues hitting $81.5 million for the fourth quarter vs. the $79.8 million consensus. The company reported GAAP net income of $133 million for the quarter ended Dec. 31, 2012, or $3.27 per diluted EPS.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription